Parenteral iron therapy exacerbates experimental sepsis Rapid Communication

Kidney International

Volumn 65, Issue 6, 2004, Pages 2108-2112

  Zager, Richard A ^a   Johnson, Ali C M ^b   Hanson, Shermy Y ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

Acute renal failure; Heme oxygenase 1; Iron sucrose; TNF

Indexed keywords

FERRIC HYDROXIDE SUCROSE; HEME OXYGENASE 1; IRON; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; ESCHERICHIA COLI; EXPERIMENT; HEART; HEAT; HYPOTHESIS; INFLAMMATION; INJECTION; IRON THERAPY; KIDNEY PARENCHYMA; MALE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEPSIS; TIME;

EID: 2442668854     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00742.x     Document Type: Article

References (34)

1. YEUN JY, LEVINE RA, MANTADILOK V, KAYSEN GA: C reactive protein predicts all cause and cardiovascular mortality in hemodialysis patients. Am J Kid Dis 35:469-476, 2000
2. OWEN WF, LOWRIE EG: C reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54:627-636, 1998
3. ZOCCALI C, BENEDETTO FA, MALLAMACI F, et al: Inflammation is associated with carotid atherosclerosis in hemodialysis patients. Creed Investigators. Cardio-vascular Risk Extended Evaluation in Dialysis Patients. J Hyperten 18:1207-1213, 2000
4. ISEKI K, TOZAWA M, YOSHI S, FUKIYAMA K: Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 14:1956-1960, 1999
5. STENVINKEL P, HEIMBURGER O, PAULTRE F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
6. RAHMAN I, MACNEE W: Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Rad Biol Med 28:1405-1420, 2000
7. HADDAD JJ: Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Sig 14:879-897, 2002
8. XIONG S, SHE H, TAKEUCHI H, et al: Signaling role of intracellular iron in NF-kappa B activation. J Biol Chem 278:17646-17654, 2003
9. SUKAMOTO H: Iron regulation of hepatic macrophage TNF alpha expression. Free Radical Biol Med 32:309-313, 2002
10. YOUNG JL, LIBBY P, SCHONBECK U: Cytokines in the pathogenesis of atherosclerosis. Thromb Haemostasis 88:554-567, 2002
11. ESPOSITO K, NAPPO F, MARFELLA R, et al: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 106:2067-2072, 2002
12. VILLA P, SACCANI A, SICA A, GHEZZI P: Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense. J Infect Dis 185:1115-1120, 2002
13. RAHMAN I, MACNEE W: Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Rad Biol Med 28:1405-1420, 2000
14. BLACKWELL TS, BLACKWELL TR, HOLDEN EP, et al: In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 157:1630-1637, 1996
15. VISSEREN FL, VERKERK MS, VAN DER BRUGGEN T, et al: Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. Eur J Clin Invest 32(Suppl 1): 84-90, 2002
16. ZAGER RA, JOHNSON ACM, HANSON SY, WASSE H: Parenteral iron formulations: A comparative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis 40:90-103, 2002
17. SALAHUDEEN AK, OLIVER B, BOWER JD, OBERTS LJ: Increase in plasma esterified F-2 isoprostanes following intravenous iron infusion in patients on hemodialysis. Kidney Int 60:1525-1531, 2001
18. ROOB JM, KHOSCHSORUR G, TIRAN A, et al: Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 8:475-486, 1997
19. LIM PS, WEI YH, YU YL, KHO B: Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol Dial Transplant 14:2680-2687, 1999
20. CAVDAR C, TEMIZ A, YENICERIOGLU Y, et al: The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients. Scand J Urol Nephrol 37:77-82, 2000
21. ROOYAKKERS TM, STROES ES, KOOISTRA MP, et al: Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. Eur J Clin Invest 32(Suppl 1): 9-16, 2002
22. AGARWAL R, VASAVADA N, SACHS NG, et al: Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int (in press)
23. ZAGER RA, PRIOR RB: Gentamicin and Gram-negative bacteremia: A synergism for the development of experimental nephrotoxic acute renal failure. J Clin Invest 78:196-204, 1986
24. ZAGER RA: Escherichia coli endotoxin injections potentiate experimental ischemic renal injury. Am J Physiol 251:F988-F994, 1986
25. ZAGER RA, JOHNSON ACM, HANSON SY: Sepsis syndrome stimulates proximal tubule cholesterol synthesis and suppresses the SR-B1 cholesterol transporter. Kidney Int 63:123-133, 2003
26. ZAGER RA, JOHNSON ACM, HANSON SY: Parenteral iron mediated nephrotoxicity: Potential mechanisms and consequences. Kidney Int 65:2108-2112, 2004
27. NATH KA, BALLA G, VERCELLOTTI GM, et al: Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90:267-270, 1992
28. NATH KA, VERCELLOTTI GM, GRANDE JP, et al: Heme protein- induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1. Kidney Int 59:106-117, 2001
29. ROXBOROUGH HE, MERCER C, MCMASTER D, et al: Plasma glutathione peroxidase activity is reduced in hemodialysis patients. Nephron 84:278-281, 2000
30. DE CAVANAGH EM, FERDER L, CARRASQUEDO F, et al: Higher levels of antioxidant defenses in enalapril-treated versus non-enalapril-treated hemodialysis patients. Am J Kid Dis 34:445-455, 1999
31. GALLI F, VARGA Z, BALLA J, et al: Vitamin D, lipid profile, and peroxidation in hemodialysis patients. Kidney Int 59(Suppl 78):S148-S154, 2001
32. BOAZ M, SMETANA S, WEINSTEIN T, et al: Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): Randomized placebo-controlled trial. Lancet 356:1213-1218, 2000
33. SENGOELGE G, KLETZMAYR J, FERRARA I, et al: Impairment of trans-endothelial leukocyte migration by iron complexes. J Am Soc Nephrol 14:2639-2644, 2002
34. BULLEN J, GRIFFITHS E, ROGERS H, WARD G: Sepsis: The critical role of iron. Microbes Infect 2:409-415, 2000